Mark Sabag
2021
In 2021, Mark Sabag earned a total compensation of $3.8M as Executive Vice President, International Markets Commercial at Teva Pharmaceutical Industries.
Compensation breakdown
| Non-Equity Incentive Plan | $732,686 |
|---|---|
| Salary | $765,294 |
| Stock Awards | $1,999,991 |
| Other | $290,770 |
| Total | $3,788,741 |
Sabag received $2M in stock awards, accounting for 53% of the total pay in 2021.
Sabag also received $732.7K in non-equity incentive plan, $765.3K in salary and $290.8K in other compensation.
Rankings
In 2021, Mark Sabag's compensation ranked 3,516th out of 12,415 executives tracked by ExecPay. In other words, Sabag earned more than 71.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,516 out of 12,415 | 72nd |
Division Manufacturing | 1,442 out of 5,508 | 74th |
Major group Chemicals And Allied Products | 584 out of 2,378 | 75th |
Industry group Drugs | 521 out of 2,099 | 75th |
Industry Pharmaceutical Preparations | 364 out of 1,549 | 77th |
Source: SEC filing on April 13, 2022.
Sabag's colleagues
We found four more compensation records of executives who worked with Mark Sabag at Teva Pharmaceutical Industries in 2021.
2021
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2021
Sven Dethlefs
Teva Pharmaceutical Industries
Executive Vice President, North America Commercial
2021
Eric Drap
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2021
Eli Kalif
Teva Pharmaceutical Industries